Literature DB >> 22490784

The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of pediatric acute lymphoblastic leukemia: update of the 2005 evidence-based review. ASBMT Position Statement.

Denise M Oliansky, Bruce Camitta, Paul Gaynon, Michael L Nieder, Susan K Parsons, Michael A Pulsipher, Hildy Dillon, Thomas A Ratko, Donna Wall, Philip L McCarthy, Theresa Hahn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22490784     DOI： 10.1016/j.bbmt.2012.03.011

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN： 1083-8791            Impact factor:   5.742


× No keyword cloud information.
  10 in total

Review 1.  Minimal residual disease-guided therapy in childhood acute lymphoblastic leukemia.

Authors:  Dario Campana; Ching-Hon Pui
Journal:  Blood       Date:  2017-02-06       Impact factor: 22.113

2.  Success of an International Learning Health Care System in Hematopoietic Cell Transplantation: The American Society of Blood and Marrow Transplantation Clinical Case Forum.

Authors:  Miguel-Angel Perales; William A Wood; Pere Barba; Linda J Burns; Mark R Litzow; Mark B Juckett; Krishna V Komanduri; Stephanie J Lee; Sean M Devlin; Luciano J Costa; Shakila Khan; Andrea King; Andreas Klein; Amrita Krishnan; Adriana Malone; Muhammad Mir; Carina Moravec; George Selby; Vivek Roy; Melissa Cochran; Melisa K Stricherz; Michael D Westmoreland
Journal:  Biol Blood Marrow Transplant       Date:  2015-12-21       Impact factor: 5.742

3.  IgH-V(D)J NGS-MRD measurement pre- and early post-allotransplant defines very low- and very high-risk ALL patients.

Authors:  Michael A Pulsipher; Chris Carlson; Bryan Langholz; Donna A Wall; Kirk R Schultz; Nancy Bunin; Ilan Kirsch; Julie M Gastier-Foster; Michael Borowitz; Cindy Desmarais; David Williamson; Michael Kalos; Stephan A Grupp
Journal:  Blood       Date:  2015-04-10       Impact factor: 22.113

Review 4.  Managing chemotherapy-related cardiotoxicity in survivors of childhood cancers.

Authors:  Steven E Lipshultz; Melissa B Diamond; Vivian I Franco; Sanjeev Aggarwal; Kasey Leger; Maria Verônica Santos; Stephen E Sallan; Eric J Chow
Journal:  Paediatr Drugs       Date:  2014-10       Impact factor: 3.022

5.  Transplant Outcomes for Children with T Cell Acute Lymphoblastic Leukemia in Second Remission: A Report from the Center for International Blood and Marrow Transplant Research.

Authors:  Michael J Burke; Michael R Verneris; Jennifer Le Rademacher; Wensheng He; Hisham Abdel-Azim; Allistair A Abraham; Jeffery J Auletta; Mouhab Ayas; Valerie I Brown; Mitchell S Cairo; Ka Wah Chan; Miguel A Diaz Perez; Christopher C Dvorak; R Maarten Egeler; Lamis Eldjerou; Haydar Frangoul; Gregory M T Guilcher; Robert J Hayashi; Ahmed Ibrahim; Kimberly A Kasow; Wing H Leung; Richard F Olsson; Michael A Pulsipher; Niketa Shah; Nirali N Shah; Elizabeth Thiel; Julie-An Talano; Carrie L Kitko
Journal:  Biol Blood Marrow Transplant       Date:  2015-08-29       Impact factor: 5.742

6.  Wide Variability in the Time Required for Immunotoxins to Kill B Lineage Acute Lymphoblastic Leukemia Cells: Implications for Trial Design.

Authors:  Fabian Müller; Tyler Cunningham; Xiu Fen Liu; Alan S Wayne; Ira Pastan
Journal:  Clin Cancer Res       Date:  2016-04-25       Impact factor: 12.531

Review 7.  New frontiers in pediatric Allo-SCT.

Authors:  J M Talano; M A Pulsipher; H J Symons; O Militano; E B Shereck; R H Giller; L Hancock; E Morris; M S Cairo
Journal:  Bone Marrow Transplant       Date:  2014-05-12       Impact factor: 5.483

8.  Intravenous Busulfan Compared with Total Body Irradiation Pretransplant Conditioning for Adults with Acute Lymphoblastic Leukemia.

Authors:  Partow Kebriaei; Claudio Anasetti; Mei-Jie Zhang; Hai-Lin Wang; Ibrahim Aldoss; Marcos de Lima; H Jean Khoury; Brenda M Sandmaier; Mary M Horowitz; Andrew Artz; Nelli Bejanyan; Stefan Ciurea; Hillard M Lazarus; Robert Peter Gale; Mark Litzow; Christopher Bredeson; Matthew D Seftel; Michael A Pulsipher; Jaap-Jan Boelens; Joseph Alvarnas; Richard Champlin; Stephen Forman; Vinod Pullarkat; Daniel Weisdorf; David I Marks
Journal:  Biol Blood Marrow Transplant       Date:  2017-12-25       Impact factor: 5.742

9.  Improved survival rate in T-cell depleted haploidentical hematopoietic cell transplantation over the last 15 years at a single institution.

Authors:  Ewelina Mamcarz; Renee Madden; Amr Qudeimat; Ashok Srinivasan; Aimee Talleur; Akshay Sharma; Ali Suliman; Gabriela Maron; Anusha Sunkara; Guolian Kang; Wing Leung; Stephen Gottschalk; Brandon M Triplett
Journal:  Bone Marrow Transplant       Date:  2019-11-18       Impact factor: 5.483

10.  Immunotherapy for pediatric leukemia.

Authors:  Nirali N Shah; Hema Dave; Alan S Wayne
Journal:  Front Oncol       Date:  2013-07-01       Impact factor: 6.244
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.